Full_Name	Preferred_Name	ICI_Target	ICI_Pathway	Is_ICI	Is_PD1	Is_CTLA4	Is_aVEGF	Is_aBRAF	Is_aMAPK	Is_Chemo	Name_Aliases	Description
Biochemo	Biochemo			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		
Trametinib	Trametinib			FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE		MEK inhibitor
Dabrafenib	Dabrafenib			FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE		MEK inhibitor; potent inhibitor of the RAF proteins BRAF and CRAF through ATP competitive binding of the active conformation of BRAF kinase
IL-2	IL-2			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		Increases NKCs
Ribociclib	Ribociclib			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		CDK inhibitor
Binimetinib	Binimetinib			FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	TRUE		MEK 1 and MEK 2 protein inhibitor
CVD	CVD			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Cisplatin, Dacarbazine, Vinblastine	
Interferon	Interferon			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		Increases NKCs
Dacarbazine	Dacarbazine			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		DTIC methylates nucleic acids, causing DNA damage resulting in growth arrest and cell death
Temozolomide	TMZ			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Temodar, Temo	methylates guanine
Dasatinib	Dasatinib			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		kinase inhibitor
Temodar	TZM			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Temozolomide, Temo	methylates guanine
TLR	TLR			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		toll-like receptor agonist
gp100 vaccine	gp100 vaccine			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		targets melanocytes
Abraxane	Abraxane			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	paclitaxel	
Carboplatin	Carboplatin			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		Platinum chemo
Doxycycline	Doxycycline			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		inhibits protein synthesis in bacteria including mitochondria; Expression of stem cell factors Oct4, Sox2, Nanog and CD44 were also significantly downregulated after doxycycline treatment
Vemurafenib	Vemurafenib			FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE		blocks BRAF; used on patients with BRAF mutation V600E
IL-21+	IL-21+			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		Increases NKCs
Cisplatin	Cisplatin			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		Platinum chemo
Velban	Velban			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		Inhibits microtuble assembly
Taxol	Taxol			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		
Trientine	Trientine			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Triethylenetetramine, TETA	telomerase inhibiting
Gleevec	Gleevec			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		Tyrosine kinase inhibitor
Nivolumab	Nivo	PD1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		immune checkpoint inhibitor
Ecorafenib	Ecorafenib			FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	FALSE		blocks BRAF; used on patients with BRAF mutation V600E
TIL	TIL			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		
MAGE	MAGE			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		CTA that triggers body to attack MAGE overexpression in melanoma
Vinblastine	Vinblastine			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		mitotic inhibitor
Trametibib	Trametibib			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		MEK inhibitor
Decarbazine	Decarbazine			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		methylates guanine
AMG 337	AMG 337			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		inhibitor of the adenosine transporter; MET kinase imhibitor
TIC	TIC			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		tumor-initiating cells
BCNU	BCNU			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		crosslinks DNA
Tamoxifen	Tamoxifen			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		blocks estrogen receptors
Paclitaxel	Paclitaxel			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Abraxane	
DCVax	DCVax			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		activated dendritic cells
ADI-PEG	ADI-PEG			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		Breaks down asparagine
GM-CSF	GM-CSF			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		improves recovery of white blood cells following chemo
M-Vax	M-Vax			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		Irradiated cancer cells
Mel44	Mel44			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		Melanoma peptides
PEG	PEG			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Pegaspargase	Breaks down asparagine
IL-10	IL-10			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		enhances vaccine-induced T cell responses
Ipilimumab	Ipi	CTLA4	CTLA4	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	Yervoy	Binds CTLA4, reducing its ability to upregulate cell division by binding C28
Pembrolizumab	Pembro	PD1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Keytruda	
MK3475	Pembro	PD1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		
ADZ2014	ADZ2014			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	Vistusertib	
CPT11	CPT11			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Camptosar, Irinotecan	
Docetaxal	Docetaxal			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Taxotere	
Vismodegib	Vismodegib			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	Erivedge	
AZD6738	AZD6738			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		impact ATR pathway checkpoint for DDR ( DNA Damage Response ) establishment
FOLFIRI	FOLFIRI			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Fonic Acid + Fluorouracil + Irinotecan	
FOLFOX	FOLFOX			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Folinic Acid + Fluorouacil + Oxiliplatin	
Ramucrimab	Ramucrimab			FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE		Binds VEGF2 antigen with high affnity preventing typical activation by VEGFR, thus downregulation of angiogeneis in tumor tissue
XELOX	XELOX			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Oxaliplatin and capecitabine	
Lapatinib	Lapatinib			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	Tykerb and Tyverb	
DXP	DXP			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	docetaxel, cisplatin and capecitabine	
DP	DP			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		
SOX	SOX			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	S-1 and oxaliplatin	
SP	SP			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	S-1 plus cisplatin	
XP	XP			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	Capecitabine and cisplatin	
Herceptin	Herceptin			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	Trastuzumab	
FGFR2	FGFR2			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		
Selumetinib	Selumetinib			FALSE	FALSE	FALSE	FALSE	FALSE	TRUE	FALSE	Koselugo	Inhibits MEP1
Volitinib	Volitinib			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		
FPA144-001	FPA144-001			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	Bemarituzumab	
ADZ1775	ADZ1775			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE		used in combination with chemo typically as it makes cells more succepble to radiation and chemo
ADZ5363	ADZ5363			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	capivasertib	
Cemiplimab	Cemiplimab	PD1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		
Atezolizumab	Atezo	PD-L1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		
Avelumab	Avelumab	PD-L1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		
Durvalumab	Durvalumab	PD-L1	PD1	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		
Sunitinib	Sunitinib			FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE		
Bevacizumab	Bev			FALSE	FALSE	FALSE	TRUE	FALSE	FALSE	FALSE		
Ironotecan	Ironotecan			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		
Lomustine	Lomustine			FALSE	FALSE	FALSE	FALSE	FALSE	FALSE	TRUE		
